Future research into non-Hodgkin lymphoma treatments needs to explore long-term outcomes and a better understanding biologic ...

Investigators are using MET immunohistochemistry testing and FDA-approved profiling tools to personalize care and address ...

Q1 2025 Earnings Call Transcript May 8, 2025 Iovance Biotherapeutics, Inc. misses on earnings expectations. Reported EPS is $ ...

Purdue University scientists have identified the Supinoxin small-molecule drug as a possible new therapy for small-cell lung ...